Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Sep;65(3):611–620. doi: 10.1086/302546

A stop-codon mutation in the human mtDNA cytochrome c oxidase I gene disrupts the functional structure of complex IV.

C Bruno 1, A Martinuzzi 1, Y Tang 1, A L Andreu 1, F Pallotti 1, E Bonilla 1, S Shanske 1, J Fu 1, C M Sue 1, C Angelini 1, S DiMauro 1, G Manfredi 1
PMCID: PMC1377967  PMID: 10441567

Abstract

We have identified a novel stop-codon mutation in the mtDNA of a young woman with a multisystem mitochondrial disorder. Histochemical analysis of a muscle-biopsy sample showed virtually absent cytochrome c oxidase (COX) stain, and biochemical studies confirmed an isolated reduction of COX activity. Sequence analysis of the mitochondrial-encoded COX-subunit genes identified a heteroplasmic G-->A transition at nucleotide position 6930 in the gene for subunit I (COX I). The mutation changes a glycine codon to a stop codon, resulting in a predicted loss of the last 170 amino acids (33%) of the polypeptide. The mutation was present in the patient's muscle, myoblasts, and blood and was not detected in normal or disease controls. It was not detected in mtDNA from leukocytes of the patient's mother, sister, and four maternal aunts. We studied the genetic, biochemical, and morphological characteristics of transmitochondrial cybrid cell lines, obtained by fusing of platelets from the patient with human cells lacking endogenous mtDNA (rho0 cells). There was a direct relationship between the proportion of mutant mtDNA and the biochemical defect. We also observed that the threshold for the phenotypic expression of this mutation was lower than that reported in mutations involving tRNA genes. We suggest that the G6930A mutation causes a disruption in the assembly of the respiratory-chain complex IV.

Full Text

The Full Text of this article is available as a PDF (3.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson S., Bankier A. T., Barrell B. G., de Bruijn M. H., Coulson A. R., Drouin J., Eperon I. C., Nierlich D. P., Roe B. A., Sanger F. Sequence and organization of the human mitochondrial genome. Nature. 1981 Apr 9;290(5806):457–465. doi: 10.1038/290457a0. [DOI] [PubMed] [Google Scholar]
  2. Andreu A. L., Bruno C., Shanske S., Shtilbans A., Hirano M., Krishna S., Hayward L., Systrom D. S., Brown R. H., Jr, DiMauro S. Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Neurology. 1998 Nov;51(5):1444–1447. doi: 10.1212/wnl.51.5.1444. [DOI] [PubMed] [Google Scholar]
  3. Bröker S., Meunier B., Rich P., Gattermann N., Hofhaus G. MtDNA mutations associated with sideroblastic anaemia cause a defect of mitochondrial cytochrome c oxidase. Eur J Biochem. 1998 Nov 15;258(1):132–138. doi: 10.1046/j.1432-1327.1998.2580132.x. [DOI] [PubMed] [Google Scholar]
  4. Chomyn A., Meola G., Bresolin N., Lai S. T., Scarlato G., Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol. 1991 Apr;11(4):2236–2244. doi: 10.1128/mcb.11.4.2236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Comi G. P., Bordoni A., Salani S., Franceschina L., Sciacco M., Prelle A., Fortunato F., Zeviani M., Napoli L., Bresolin N. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol. 1998 Jan;43(1):110–116. doi: 10.1002/ana.410430119. [DOI] [PubMed] [Google Scholar]
  6. DiMauro S., Servidei S., Zeviani M., DiRocco M., DeVivo D. C., DiDonato S., Uziel G., Berry K., Hoganson G., Johnsen S. D. Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol. 1987 Oct;22(4):498–506. doi: 10.1002/ana.410220409. [DOI] [PubMed] [Google Scholar]
  7. Gattermann N., Retzlaff S., Wang Y. L., Hofhaus G., Heinisch J., Aul C., Schneider W. Heteroplasmic point mutations of mitochondrial DNA affecting subunit I of cytochrome c oxidase in two patients with acquired idiopathic sideroblastic anemia. Blood. 1997 Dec 15;90(12):4961–4972. [PubMed] [Google Scholar]
  8. Hanna M. G., Nelson I. P., Rahman S., Lane R. J., Land J., Heales S., Cooper M. J., Schapira A. H., Morgan-Hughes J. A., Wood N. W. Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am J Hum Genet. 1998 Jul;63(1):29–36. doi: 10.1086/301910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holt I. J., Harding A. E., Morgan-Hughes J. A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature. 1988 Feb 25;331(6158):717–719. doi: 10.1038/331717a0. [DOI] [PubMed] [Google Scholar]
  10. Holt I. J., Harding A. E., Petty R. K., Morgan-Hughes J. A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990 Mar;46(3):428–433. [PMC free article] [PubMed] [Google Scholar]
  11. Houshmand M., Larsson N. G., Holme E., Oldfors A., Tulinius M. H., Andersen O. Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy. Biochim Biophys Acta. 1994 Apr 12;1226(1):49–55. doi: 10.1016/0925-4439(94)90058-2. [DOI] [PubMed] [Google Scholar]
  12. Keightley J. A., Hoffbuhr K. C., Burton M. D., Salas V. M., Johnston W. S., Penn A. M., Buist N. R., Kennaway N. G. A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria. Nat Genet. 1996 Apr;12(4):410–416. doi: 10.1038/ng0496-410. [DOI] [PubMed] [Google Scholar]
  13. King M. P., Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 1989 Oct 27;246(4929):500–503. doi: 10.1126/science.2814477. [DOI] [PubMed] [Google Scholar]
  14. King M. P., Koga Y., Davidson M., Schon E. A. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Mol Cell Biol. 1992 Feb;12(2):480–490. doi: 10.1128/mcb.12.2.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Manfredi G., Schon E. A., Moraes C. T., Bonilla E., Berry G. T., Sladky J. T., DiMauro S. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord. 1995 Sep;5(5):391–398. doi: 10.1016/0960-8966(94)00079-o. [DOI] [PubMed] [Google Scholar]
  17. Marusich M. F., Robinson B. H., Taanman J. W., Kim S. J., Schillace R., Smith J. L., Capaldi R. A. Expression of mtDNA and nDNA encoded respiratory chain proteins in chemically and genetically-derived Rho0 human fibroblasts: a comparison of subunit proteins in normal fibroblasts treated with ethidium bromide and fibroblasts from a patient with mtDNA depletion syndrome. Biochim Biophys Acta. 1997 Dec 31;1362(2-3):145–159. doi: 10.1016/s0925-4439(97)00061-6. [DOI] [PubMed] [Google Scholar]
  18. Marzuki S., Noer A. S., Lertrit P., Thyagarajan D., Kapsa R., Utthanaphol P., Byrne E. Normal variants of human mitochondrial DNA and translation products: the building of a reference data base. Hum Genet. 1991 Dec;88(2):139–145. doi: 10.1007/BF00206061. [DOI] [PubMed] [Google Scholar]
  19. Mitochondrial encephalomyopathies: gene mutation. Neuromuscul Disord. 1999 Jan;9(1):XV–XXII. [PubMed] [Google Scholar]
  20. Moraes C. T., Schon E. A., DiMauro S., Miranda A. F. Heteroplasmy of mitochondrial genomes in clonal cultures from patients with Kearns-Sayre syndrome. Biochem Biophys Res Commun. 1989 Apr 28;160(2):765–771. doi: 10.1016/0006-291x(89)92499-6. [DOI] [PubMed] [Google Scholar]
  21. Polyak K., Li Y., Zhu H., Lengauer C., Willson J. K., Markowitz S. D., Trush M. A., Kinzler K. W., Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 1998 Nov;20(3):291–293. doi: 10.1038/3108. [DOI] [PubMed] [Google Scholar]
  22. Rieder M. J., Taylor S. L., Tobe V. O., Nickerson D. A. Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome. Nucleic Acids Res. 1998 Feb 15;26(4):967–973. doi: 10.1093/nar/26.4.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Robinson B. H. Use of fibroblast and lymphoblast cultures for detection of respiratory chain defects. Methods Enzymol. 1996;264:454–464. doi: 10.1016/s0076-6879(96)64041-5. [DOI] [PubMed] [Google Scholar]
  24. Schon E. A., Bonilla E., DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr. 1997 Apr;29(2):131–149. doi: 10.1023/a:1022685929755. [DOI] [PubMed] [Google Scholar]
  25. Schägger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987 Nov 1;166(2):368–379. doi: 10.1016/0003-2697(87)90587-2. [DOI] [PubMed] [Google Scholar]
  26. Shoubridge E. A., Johns T., Boulet L. Use of myoblast cultures to study mitochondrial myopathies. Methods Enzymol. 1996;264:465–475. doi: 10.1016/s0076-6879(96)64042-7. [DOI] [PubMed] [Google Scholar]
  27. Taanman J. W. Human cytochrome c oxidase: structure, function, and deficiency. J Bioenerg Biomembr. 1997 Apr;29(2):151–163. doi: 10.1023/a:1022638013825. [DOI] [PubMed] [Google Scholar]
  28. Tiranti V., Hoertnagel K., Carrozzo R., Galimberti C., Munaro M., Granatiero M., Zelante L., Gasparini P., Marzella R., Rocchi M. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet. 1998 Dec;63(6):1609–1621. doi: 10.1086/302150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tritschler H. J., Bonilla E., Lombes A., Andreetta F., Servidei S., Schneyder B., Miranda A. F., Schon E. A., Kadenbach B., DiMauro S. Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology. 1991 Feb;41(2 ):300–305. doi: 10.1212/wnl.41.2_part_1.300. [DOI] [PubMed] [Google Scholar]
  30. Tsukihara T., Aoyama H., Yamashita E., Tomizaki T., Yamaguchi H., Shinzawa-Itoh K., Nakashima R., Yaono R., Yoshikawa S. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science. 1996 May 24;272(5265):1136–1144. doi: 10.1126/science.272.5265.1136. [DOI] [PubMed] [Google Scholar]
  31. Wallace D. C., Singh G., Lott M. T., Hodge J. A., Schurr T. G., Lezza A. M., Elsas L. J., 2nd, Nikoskelainen E. K. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988 Dec 9;242(4884):1427–1430. doi: 10.1126/science.3201231. [DOI] [PubMed] [Google Scholar]
  32. Zhu Z., Yao J., Johns T., Fu K., De Bie I., Macmillan C., Cuthbert A. P., Newbold R. F., Wang J., Chevrette M. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet. 1998 Dec;20(4):337–343. doi: 10.1038/3804. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES